Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Andrew Lodge.

Newcastle AuthorsTitleYearFull text
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Type 1 growth factor receptor expression in node positive breast cancer: Adverse prognostic significance of c-erbB-42003
Dr Brian Angus
Professor John Lunec
Dr Stephen Crosier
Andrew Lodge
Dr John Anderson
et al.
Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues2002
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Expression of topoisomerase III alpha in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody2000
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Expression of topoisomerase IIIα in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody2000
Andrew Lodge
Dr John Anderson
Dr Brian Angus
Pixel-based image cytometry for quantification of nuclear antigen expression using Adobe Photoshop2000
Andrew Lodge
Dr John Anderson
Dr Beate Haugk
Dr Brian Angus
Type 1 growth factor receptor and topoisomerase expression in breast cancer: Adverse prognostic significance of c-erbB-42000
Andrew Lodge
Dr Andrew Hall
Dr Katrina Wood
Dr John Anderson
Dr Brian Angus
et al.
NCL-CD10-270: A new monoclonal antibody recognizing CD10 in paraffin- embedded tissue1999
Andrew Lodge
Dr Andrew Hall
Dr John Anderson
Dr Michael Reid
Dr Brian Angus
et al.

A study of the prognostic significance of topoisomerase IIα in childhood acute lymphoblastic Leukaemia

1998